This is supported by the report from advanced metastatic colorectal cancer, in which patients with intact ATM (85%: 192 of 227 patients) had significantly poor overall survival compared with those with ATM mutations (15%: 35 of 227 patients) [45]. Here, ATM is linked to metastatic colorectal cancer.